What's breaking now, across thousands of outlets.
Mirum’s hepatitis D treatment has succeeded in the second of two pivotal trials. Now comes the next challenge: competing with rivals in a growing market. The Phase 3 trial, called AZURE-4, enrolled 113 treatment-naïve patients ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Moments before going into surgery, Hayley Deniss was told about a potential disruption to her IVF care.
Around 700 people took to the streets of Salobreña on Sunday, November 8, to support the fight against cancer at […]
(MedPage Today) -- The vice president of publications at the American Diabetes Association (ADA) has resigned amid the ongoing boycott of the organization.
Norovirus has no approved vaccine or treatment. Learn its symptoms, how it spreads and the habits that protect your household this winter.
People with eczema often develop allergic asthma during the course of their lives. The reason for this is still largely unclear.
Sen. Bernie Sanders said that he wants to lower the Medicare eligibility age by 10 years, among other initiatives.
